Siemens' move to become first full-service diagnostics firm has rivals taking note
This article was originally published in Clinica
Executive Summary
Siemens Medical Solutions formally entered the in vitro diagnostics industry on July 27, when it finalised its $1.86bn acquisition of the immunoassay company, Diagnostic Products Corporation (DPC).